Methods for Implementing Microbeam Radiation Therapy

• US 20080192892A1
• Filed: 02/10/2006
• Published: 08/14/2008
• Est. Priority Date: 02/10/2005
• Status: Abandoned Application

• Current Assignee: Brookhaven Science Associates, LLC (Government of the United States of America)
• Original Assignee: Brookhaven Science Associates, LLC (Government of the United States of America)
• Inventors: Dilmanian, F. Avraham, Hainfeld, James, Morris, Gerard M.
• Application Number:
  US11/884,179
• Publication Number:
  US 20080192892A1
• Time in Patent Office: Days
• US Class Current: 378/65
• CPC Class Codes: A61N 2005/109 Neutrons
• CPC Class Codes: A61N 2005/1091 Kilovoltage or orthovoltage range photons
• CPC Class Codes: A61N 2005/1098 Enhancing the effect of the particle by an injected agent or implanted device
• CPC Class Codes: A61N 5/1045 using a multi-leaf collimator, e.g. for intensity modulated radiation therapy or IMRT

Abstract

A method of performing microbeam radiation therapy (MRT) includes delivering a dose only to selected tissue in a target volume (10) with continuous broad beam, first, by interleaving arrays of microplanar beams (30,36) only at the target (10). Administered contrast agents can supplement the effect by preferentially increasing the target dose relative to dose in normal tissue. A broad beam effect is alternatively created using non-interleaving microbeam array(s) with scattering agents administered to selected tissue that preferentially increase valley dose (69) within target to approximate broad beam. The methods of interleaving microbeams are also applied to treat diseases and conditions by ablating at least a portion of selected tissue, or by damaging blood-brain barrier for efficient drug and/or cell administration. A system for performing interlaced microbeam radiosurgery preferably includes two orthogonal radiation source arms (102) for producing and interleaving microbeam arrays (30,36) at the target volume (10). The methods treat tumors, pain, epilepsy, and neurological diseases.

Claims

1. A method of performing radiation therapy on a subject comprising:

delivering a therapeutic dose of high energy electromagnetic radiation substantially only to a target tissue by generating a broad beam radiation effect substantially only within the target tissue, the broad beam radiation effect not being generated in non-target tissue, said delivering comprising irradiating the target tissue with at least one array of microbeams, the at least one array comprising at least two parallel, spatially distinct microbeams.

2. The method of claim 1, wherein the at least one array comprises at least two non-intersecting arrays of microbeams, said delivering further comprising:

interleaving the at least two non-intersecting arrays substantially only within the target tissue to form a substantially continuous broad beam of radiation substantially only within the target tissue.

3. The method of claim 2, wherein each of the at least two parallel, spatially distinct microbeams comprises a beam thickness, a beam width, and a beam plane, wherein the at least two non-intersecting arrays comprise parallel beam planes and an inter-beam spacing between adjacent microbeams, the inter-beam spacing in each of the at least two non-intersecting arrays being substantially equal to or greater than the beam thickness, said interleaving further comprising:

irradiating the target tissue in a first irradiation direction with a first one of the at least two non-intersecting arrays of microbeams;

angularly displacing a second one of the at least two non-intersecting arrays from the first one of the at least two non-intersecting arrays by rotating one of the subject and a source generating the at least two non-intersecting arrays about an axis positioned through a center of the target tissue, the axis being perpendicular to the parallel beam planes;

translating the second one of the at least two non-intersecting arrays in a direction perpendicular to the parallel beam planes by a distance substantially equal to or greater than the beam thickness; and

irradiating the target tissue in a second irradiation direction with the second one of the at least two non-intersecting arrays.

4. The method of claim 3, wherein the spacing is substantially equal to the beam thickness, and wherein the translating distance is substantially equal to the beam thickness.

5. The method of claim 3, wherein the at least two non-intersecting arrays of microbeams are angularly displaced by about ninety (90) degrees.

6. The method of claim 3, wherein the beam thickness is substantially in a range greater than or equal to about 20 micrometers and less than or equal to about 1000 micrometers.

7. The method of claim 3, wherein the beam thickness is substantially in a range greater than or equal to about 500 micrometers and less than or equal to about 1000 micrometers.

8. The method of claim 3, further comprising repeating the steps of angularly displacing, translating, and irradiating in the second irradiation direction a number of times, a total number of n irradiations covering a 360°

angular space around the target tissue.

9. The method of claim 8, said angularly displacing further comprising angularly displacing by an amount substantially equal to 360 degrees divided by n, said translating comprising translating by a distance substantially equal to the beam thickness, wherein said spacing is substantially equal to the product of the beam thickness and (n−

1).

10. The method of claim 1, wherein said delivering further comprises administering the therapeutic dose over more than one session in dose fractionations, a sum of the dose fractionations being substantially equal to the therapeutic dose.

11. The method of claim 10, wherein said delivering further comprises separating the more than one session over a time interval within a range of about 12 hours to about five days.

12. The method of claim 2, further comprising providing a concentration of a radiation contrast agent substantially only to the target tissue, the concentration enhancing an in-beam dose of the high energy electromagnetic radiation in each of the at least two parallel, spatially distinct microbeams of the at least two non-intersecting arrays interleaved substantially only within the target tissue.

13. The method of claim 12, wherein the radiation contrast agent comprises a K-edge of at least 65 keV.

14. The method of claim 12, wherein the radiation contrast agent comprises metal nanoparticles.

15. The method of claim 12, wherein the metal nanoparticles comprise at least one of tungsten and gold.

16. The method of claim 1, further comprising providing a concentration of a radiation scattering agent substantially only to the target tissue, the radiation scattering agent scattering the high energy electromagnetic radiation in a substantially perpendicular direction to an irradiation direction of the at least one microbeam array and raising a valley dose between each of the at least two parallel, spatially distinct microbeams substantially only within the target tissue, said raising of the valley dose relative to an in-beam dose generating the broad beam radiation effect substantially only within the target tissue.

17. The method of claim 16, wherein the at least one array is one of a single microbeam array and at least two cross-fired arrays that intersect substantially only within the target tissue, the at least two parallel, spatially distinct microbeams comprising a beam thickness and an inter-beam spacing, wherein the inter-beam spacing is greater than a spacing that would induce damage to normal tissue irradiated by the at least one array.

18. The method of claim 16, wherein the radiation scattering agent comprises at least one of gadolinium and iodine.

19. The method of claim 1, wherein the high energy electromagnetic radiation comprises X-ray radiation.

20. The method of claim 19, wherein the X-ray radiation comprises bremsstrahlung radiation.

21. The method of claim 1, wherein the target tissue comprises one of an ocular tumor and a brain tumor.

22. The method of claim 3, wherein the target tissue comprises ocular melanoma, wherein the high energy electromagnetic radiation comprises X-ray radiation, and wherein each of the at least two parallel, spatially distinct microbeams comprises a dose fall off of less than about 30 micrometers.

23. A method of performing radiation therapy on a subject comprising:

delivering a therapeutic dose of X-ray radiation substantially only to a target tissue by generating a broad beam radiation effect substantially only within the target tissue, said delivering comprising;

irradiating the target tissue in an irradiation direction with at least one array of microbeams, the at least one array comprising at least two parallel, spatially distinct microbeams; and

providing a concentration of a radiation scattering agent substantially only to the target tissue, the radiation scattering agent scattering the X-ray radiation in a substantially perpendicular direction to the irradiation direction and raising a valley dose between each of the at least two parallel, spatially distinct microbeams.

24. The method of claim 23, wherein the radiation scattering agent includes an atomic number of less than or equal to 70.

25. The method of claim 23, wherein the radiation scattering agent includes one of gadolinium and iodine.

26. A method of performing radiation therapy on a subject comprising:

delivering a therapeutic dose of X-ray radiation substantially only to a target tissue by generating a substantially continuous broad beam of radiation substantially only to the target tissue, said delivering comprising;

irradiating the target tissue with at least two non-intersecting microbeam arrays, each of the at least two non-intersecting microbeam arrays comprising at least two parallel, spatially distinct microbeams, wherein each of the at least two parallel, spatially distinct microbeams comprises a beam thickness, a beam width, and a beam plane, and wherein the at least two non-intersecting arrays comprise parallel beam planes and an inter-beam spacing between adjacent microbeams, the inter-beam spacing in each of the at least two non-intersecting arrays being substantially equal to or greater than the beam thickness;

interleaving the at least two non-intersecting microbeam arrays substantially only within the target tissue to form the substantially continuous broad beam of radiation, said interleaving further comprising;

irradiating the target tissue in a first irradiation direction with a first one of the at least two non-intersecting arrays of microbeams;

angularly displacing a second one of the at least two non-intersecting arrays from the first one of the at least two non-intersecting arrays by rotating one of the subject and a source generating the at least two non-intersecting arrays about an axis positioned through a center of the target tissue, the axis being perpendicular to the parallel beam planes;

translating the second one of the at least two non-intersecting arrays in a direction perpendicular to the parallel beam planes by a distance substantially equal to the beam thickness; and

irradiating the target tissue in a second irradiation direction with the second one of the at least two non-intersecting arrays.

27. The method of claim 26, further comprising providing a concentration of a radiation contrast agent substantially only to the target tissue, the concentration enhancing an in-beam dose of the X-ray radiation in each of the at least two parallel, spatially distinct microbeams of the at least two non-intersecting arrays interleaved substantially only within the target tissue.

28. The method of claim 27, wherein the radiation contrast agent comprises metal nanoparticles, the metal nanoparticles comprising at least one of tungsten and gold.

29. A method of performing radiation therapy on a subject suffering from a disease or condition, the method comprising:

delivering a dose of high energy electromagnetic radiation to selected tissue in a target volume in an amount sufficient to damage or ablate at least a portion of the selected tissue without inducing permanent damage to tissue external to the target volume by generating a broad beam radiation effect only within the target volume, said delivering comprising;

irradiating the selected tissue with at least two arrays of microbeams, each of the at least two arrays comprising at least two parallel, spatially distinct microbeams; and

interleaving the at least two arrays at the target volume to form a substantially continuous broad beam of radiation within the selected tissue in the target volume defined by the interleaved microbeams.

30. The method of claim 29, wherein the high energy electromagnetic radiation comprises X-ray radiation, and wherein the dose is an amount of radiation sufficient to ablate at least a portion of the selected tissue.

31. The method of claim 30, the method comprising performing radiation therapy on a subject to treat epilepsy, wherein the selected tissue comprises epileptogenic foci.

32. The method of claim 30, the method comprising performing radiation therapy on a subject to treat pain, wherein the selected tissue comprises the central nervous system pain center.

33. The method of claim 30, wherein the selected tissue comprises brain tissue associated with one of an adenoma and a neurological disease.

34. The method of claim 30, wherein the selected tissue comprises at least a portion of a globus pallidus.

35. The method of claim 29, the method further comprising delivering at least one of pharmaceuticals and cells to the selected tissue to treat a disease, and wherein the dose of high energy electromagnetic radiation is sufficient to enhance and speed up said delivering.

36. The method of claim 35, wherein the selected tissue comprises at least one of a thalamus or subthalamic nuclei.

37. The method of claim 35, wherein the cells comprise at least one of endogenous cells, external stem cells, and immune cells for treating the disease.

38. The method of claim 35, wherein the selected tissue is a cancerous tumor, and wherein the pharmaceuticals comprise chemotherapy pharmaceuticals.

39. The method of claim 35, wherein the selected tissue is a cancerous tumor, the method further comprising administering a stable isotope of boron to the cancerous tumor by attaching it to tumor seeking compounds and delivering the tumor seeking compounds to the cancerous tumor.

40. The method of claim 37, the method comprising performing radiation therapy on a subject to treat epilepsy, wherein the selected tissue comprises epileptogenic tissue, and wherein the at least one of pharmaceuticals and cells comprises gamma aminobutyric acid (GABA) producing cells.

41. The method of claim 36, the method comprising performing radiation therapy on a subject to treat Parkinson'"'"'s disease, and wherein the dose is in a range of about 130 Gy to about 150 Gy.

42. A system for performing interlaced microbeam radiosurgery on a selected tissue of a subject, the system comprising:

two radiation source arms for producing two non-intersecting arrays of microplanar beams of high energy electromagnetic radiation, each radiation source arm comprising a radiation source and a slit positioned downstream from the radiation source for forming the microplanar beams, the two radiation source arms beams configured and aligned to interleave the two non-intersecting arrays within a target volume comprising the selected tissue.

43. The system of claim 42, wherein the two radiation source arms are substantially orthogonal.

44. The system of claim 42, wherein the slit is a single slit for forming one microplanar beam, and wherein each arm further comprises a motorized stage for translating the slit to form the corresponding non-intersecting array.

45. The system of claim 42, each arm further comprising a bolus downstream of the slit.

46. The system of claim 42, wherein the slit is a multi slit collimator for forming the microplanar radiation beams of the corresponding array simultaneously.

47. The system of claim 42, further comprising a dosimetry monitor positioned in a path of each of the two non-intersecting arrays in close proximity to the subject.

49. The system of claim 43, further comprising an opposing radiation source arm for one of the two orthogonal radiation source arms, wherein the opposing radiation source arm and corresponding orthogonal arm are separated by an angle of 180°

around an axis of rotation through the target tissue, the opposing radiation source arm and corresponding source arm producing oppositely directed and coincident microplanar beam arrays within the target volume.

50. The system of claim 42, wherein the radiation source comprises an orthovoltage x-ray tube.

48. The system of claim 48, further comprising at least one shutter upstream of the dosimetry monitor to control the therapeutic dose administered to the subject.